Journal of Clinical Medicine (Jan 2022)

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

  • Paweł Rajewski,
  • Dorota Zarębska-Michaluk,
  • Ewa Janczewska,
  • Andrzej Gietka,
  • Włodzimierz Mazur,
  • Magdalena Tudrujek-Zdunek,
  • Krzysztof Tomasiewicz,
  • Teresa Belica-Wdowik,
  • Barbara Baka-Ćwierz,
  • Dorota Dybowska,
  • Waldemar Halota,
  • Beata Lorenc,
  • Marek Sitko,
  • Aleksander Garlicki,
  • Hanna Berak,
  • Andrzej Horban,
  • Iwona Orłowska,
  • Krzysztof Simon,
  • Łukasz Socha,
  • Marta Wawrzynowicz-Syczewska,
  • Jerzy Jaroszewicz,
  • Zbigniew Deroń,
  • Agnieszka Czauż-Andrzejuk,
  • Jolanta Citko,
  • Rafał Krygier,
  • Anna Piekarska,
  • Łukasz Laurans,
  • Witold Dobracki,
  • Jolanta Białkowska,
  • Olga Tronina,
  • Magdalena Wietlicka-Piszcz,
  • Małgorzata Pawłowska,
  • Robert Flisiak

DOI
https://doi.org/10.3390/jcm11020379
Journal volume & issue
Vol. 11, no. 2
p. 379

Abstract

Read online

HCV infection is one of the main reasons for liver cirrhosis and hepatocellular carcinoma. In recent years, one finds more and more extrahepatic manifestations of HCV infection, including its possible influence on the development of diabetes. In the presented work, one finds the frequency analysis of the incidence of diabetes among 2898 HCV infected patients treated in Poland, and the assessment of their relevance to the HCV genotype and the progression of fibrosis. The results indicate that the hepatitis C infection seems to be a risk factor for diabetes in persons with more advanced liver fibrosis, for older people, and for the male gender. Thus, one found no differences regarding the frequency of its incidence depending on HCV genotype, including genotype 3.

Keywords